Charles River Laboratories International Inc
NYSE:CRL
Charles River Laboratories International Inc
Operating Income
Charles River Laboratories International Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Charles River Laboratories International Inc
NYSE:CRL
|
Operating Income
$659.3m
|
CAGR 3-Years
13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
16%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Operating Income
$7.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
15%
|
|
Danaher Corp
NYSE:DHR
|
Operating Income
$9.5B
|
CAGR 3-Years
20%
|
CAGR 5-Years
26%
|
CAGR 10-Years
12%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Operating Income
$1.1B
|
CAGR 3-Years
11%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Agilent Technologies Inc
NYSE:A
|
Operating Income
$1.3B
|
CAGR 3-Years
11%
|
CAGR 5-Years
6%
|
CAGR 10-Years
16%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Operating Income
$2.1B
|
CAGR 3-Years
38%
|
CAGR 5-Years
21%
|
CAGR 10-Years
16%
|
See Also
What is Charles River Laboratories International Inc's Operating Income?
Operating Income
659.3m
USD
Based on the financial report for Dec 30, 2023, Charles River Laboratories International Inc's Operating Income amounts to 659.3m USD.
What is Charles River Laboratories International Inc's Operating Income growth rate?
Operating Income CAGR 10Y
16%
Over the last year, the Operating Income growth was 0%. The average annual Operating Income growth rates for Charles River Laboratories International Inc have been 13% over the past three years , 13% over the past five years , and 16% over the past ten years .